Alterations of circulating endothelial progenitor cells in patients with bronchiectasis and underlying mechanism

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000034604

Enrollment

Unknown

Registered

2020-07-11

Start date

2020-07-13

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiectasis

Interventions

broniectasis group:Nil

Healthy control group:Nil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years old; 2. High resolutioncomputed tomography (HRCT)revealed bronchiectasis that was consistent withrespiratory symptoms; 3. Clinically stable, and no antibiotic usein the preceding 4 weeks.

Exclusion criteria

Exclusion criteria: Subjects who presented with severe cardiovascular diseases, uncontrolled hypertension, malignant diseases, and smoking

Design outcomes

Primary

Measure	Time frame
circulating endothelial progenitor cells;	—

Countries

China

Contacts

Public ContactXinyan Huang

The First Affiliated Hospital of Sun Yat-Sen University

sysuhxy@163.com+86 13632424725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026